Antimicrobial sales profile in Brazil from 2014 to 2021: analysis of records from the National System of Controlled Products Management
Revista Brasileira de Epidemiologia · 2025
DOI: 10.1590/1980-549720250040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Brasileira de Epidemiologia, 2025. Verfasst von Jakeline Ribeiro Barbosa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fundação Oswaldo Cruz, Universidade Aberta do Sistema Único de Saúde, Executiva Secretariat - Brasília (DF), Brazil. Hauptthemen laut MEDLINE: Anti-Infective Agents, Commerce. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To analyze the antimicrobial dispensing profile in Brazil from 2014 to 2021 based on records from the Brazilian National System of Controlled Products Management (SNGPC) of the Brazilian Health Regulatory Agency (Anvisa).
Methods
A descriptive, time-series ecological study was carried out using data from private pharmacies and drugstores on the sale of antimicrobial drugs. Drugs sold from January 2014 to November 2021 were included, with analysis of the variables of month, year, municipality, state, active ingredient, prescriber’s professional council, and patient’s sex and age.
Results
During the study period, 532,518,866 sales of special control drugs were recorded in SNGPC, 66.8% of which were antimicrobials. There was an increase in sales up to 2019, with a decrease in 2020, during the COVID-19 pandemic, and a new increase in 2021. The Southeast and Northeast regions concentrated the highest sales, with the Southeast leading. Sales were higher among women, especially in the 30 to 44.9 age group, with an increase in sales among patients aged 60 or older. The best-selling antimicrobials were amoxicillin, azithromycin, ciprofloxacin and cephalexin.
Conclusion
The study reveals differences in consumption by region, sex, and age, and it highlights the importance of educational interventions for the responsible use of antimicrobials. It also points out that the suspension of mandatory data registration in SNGPC may compromise the monitoring necessary to combat bacterial resistance and improve public health in Brazil.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fundação Oswaldo Cruz, Universidade Aberta do Sistema Único de Saúde, Executiva Secretariat - Brasília (DF), Brazil.
- Ministry of Health, Secretariat of Science, Technology and Innovation and the Health Economic-Industrial Complex, Department of Science and Technology - Brasília (DF), Brazil.
- Fundação Oswaldo Cruz, Evidence for Health Policy and Technology Program - Brasília (DF), Brazil.
- Fundação Oswaldo Cruz, Epidemiology and Health Surveillance Center - Brasília (DF), Brazil.
Zitieren
APA
Barbosa, J. R., França, G. V. A., Andrade, A. M., Araújo, B. T., Henriques, C. M. P., & Verotti, M. P. (2025). Antimicrobial sales profile in Brazil from 2014 to 2021: analysis of records from the National System of Controlled Products Management. Revista Brasileira de Epidemiologia. https://doi.org/10.1590/1980-549720250040
Vancouver
Barbosa JR, França GVA, Andrade AM, Araújo BT, Henriques CMP, Verotti MP. Antimicrobial sales profile in Brazil from 2014 to 2021: analysis of records from the National System of Controlled Products Management. Revista Brasileira de Epidemiologia. 2025. doi:10.1590/1980-549720250040
BibTeX
@article{Barbosa2025,
author = {Barbosa, Jakeline Ribeiro and França, Giovanny Vinícius Araújo de and Andrade, Aurélio Matos and Araújo, Beatriz Torres and Henriques, Cláudio Maierovitch Pessanha and Verotti, Mariana Pastorello},
title = {Antimicrobial sales profile in Brazil from 2014 to 2021: analysis of records from the National System of Controlled Products Management},
journal = {Revista Brasileira de Epidemiologia},
year = {2025},
doi = {10.1590/1980-549720250040}
}
EUVIMED